Lipid peroxidation products as predictors of oxidant-mediated disease in preterm infants
Lipid peroxidation products as predictors of oxidant-mediated disease in preterm infants
复制标题
DOI:
10.1080/14767058.2020.1869934
复制
发表时间:
2020-12-29
影响因子:
1.8
通讯作者:
Weinberger, Barry
中科院分区:
文献类型:
--
作者:
Katti, Karishma;Ayasolla, Kamesh R.;Weinberger, Barry
BackgroundPreterm infants are susceptible to "oxygen radical diseases" (ORD). 8-isoprostane (8-IP) is a bioactive eicosanoid generated by reactive oxygen species-catalyzed peroxidation of arachidonic acid. Malondialdehyde (MDA) is generated by the decomposition of oxidant-induced lipid hydroperoxides. We hypothesize that the development of ORD is associated with elevated plasma 8-IP on day 0-1, and increasing urine levels of MDA in the first month.MethodsPreterm (= stage 1, pneumatosis, or oxygen requirement at 36 weeks corrected gestational age.ResultsPlasma 8-IP was higher on day 0-1 in preterm infants who developed ORD compared to term infants. Urine TBARS levels increased in preterm infants from day 0-1 to day 28 but were not different in infants with or without ORD. Preterm infants who developed ORD demonstrated a significant rise in urine TBARS levels from day 1 to 14.ConclusionsElevated plasma 8-IP on day 1 is associated with ORD in preterm infants. If validated as a biomarker for ORD, it may be useful in directing antioxidant therapies to the most susceptible infants. Urine TBARS during the first month are not significantly different in term infants, preterm infants with ORD, and preterm infants without ORD, but rapid rise of TBARS in the first 2 weeks may be associated with ORD.